Equity ETFs Silver Lining for Biotechnology ETFs After Pfizer Calls off Allergan Deal By Max ChenApril 6, 2016
ETF Strategist Channel Turning Tides With Master Limited Partnerships By Adam Grossman & Scott Hays, Riverfront Investment GroupMarch 7, 2016